State Street Corp cut its position in Envision Healthcare Corporation (NYSE:EVHC) by 1.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,800,248 shares of the company’s stock after selling 62,473 shares during the period. State Street Corp owned 4.10% of Envision Healthcare Corporation worth $300,827,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Schwab Charles Investment Management Inc. grew its stake in shares of Envision Healthcare Corporation by 5.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 632,195 shares of the company’s stock valued at $39,620,000 after buying an additional 33,587 shares during the period. BB&T Corp lifted its position in Envision Healthcare Corporation by 18.2% in the 2nd quarter. BB&T Corp now owns 109,144 shares of the company’s stock valued at $6,840,000 after acquiring an additional 16,769 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Envision Healthcare Corporation by 12.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 47,826 shares of the company’s stock valued at $2,997,000 after acquiring an additional 5,454 shares in the last quarter. Maverick Capital Ltd. lifted its position in Envision Healthcare Corporation by 66.2% in the 2nd quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock valued at $319,197,000 after acquiring an additional 2,028,026 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. lifted its position in Envision Healthcare Corporation by 0.8% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 339,630 shares of the company’s stock valued at $21,285,000 after acquiring an additional 2,601 shares in the last quarter.

Shares of Envision Healthcare Corporation (NYSE:EVHC) opened at 40.74 on Monday. Envision Healthcare Corporation has a 1-year low of $39.66 and a 1-year high of $74.75. The company’s market capitalization is $4.77 billion. The firm has a 50-day moving average of $46.50 and a 200 day moving average of $54.68.

Envision Healthcare Corporation (NYSE:EVHC) last issued its quarterly earnings data on Monday, August 7th. The company reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.75 by $0.04. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. The business had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.96 billion. During the same period last year, the company posted $0.34 EPS. The business’s revenue was up 156.7% on a year-over-year basis. On average, analysts anticipate that Envision Healthcare Corporation will post $1.40 EPS for the current year.

Envision Healthcare Corporation announced that its board has initiated a stock buyback program on Monday, September 18th that permits the company to repurchase $250.00 million in shares. This repurchase authorization permits the company to buy up to 4.5% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s management believes its shares are undervalued.

COPYRIGHT VIOLATION NOTICE: “State Street Corp Trims Stake in Envision Healthcare Corporation (EVHC)” was originally posted by Daily Political and is the property of of Daily Political. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/10/16/state-street-corp-trims-stake-in-envision-healthcare-corporation-evhc.html.

EVHC has been the topic of several recent research reports. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $80.00 price target on shares of Envision Healthcare Corporation in a research report on Tuesday, July 4th. Zacks Investment Research raised shares of Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 target price on the stock in a research report on Tuesday, July 4th. Jefferies Group LLC set a $71.00 target price on shares of Envision Healthcare Corporation and gave the stock a “buy” rating in a research report on Thursday, August 24th. Royal Bank Of Canada lifted their target price on shares of Envision Healthcare Corporation from $72.00 to $77.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 27th. Finally, BidaskClub cut shares of Envision Healthcare Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. One research analyst has rated the stock with a sell rating, two have issued a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. Envision Healthcare Corporation presently has an average rating of “Buy” and a consensus target price of $73.30.

About Envision Healthcare Corporation

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corporation (NYSE:EVHC).

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.